New Key Statistics Module, Z-Score and F-Score
NAS:ALXN Key Ratios
| Market Cap $ M | 40,336.01 |
| Enterprise Value $ M | 39,583.71 |
| P/E(ttm) | 59.16 |
| PE Ratio without NRI | 59.16 |
| Forward PE Ratio | 13.85 |
| Price/Book | 3.22 |
| Price/Sales | 6.41 |
| Price/Free Cash Flow | 13.99 |
| Price/Owner Earnings | 89.54 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 6,261.00 |
| EPS (TTM) $ | 3.06 |
| Beneish M-Score | -2.43 |
| 10-y EBITDA Growth Rate % | 19.40 |
| 5-y EBITDA Growth Rate % | 11.70 |
| y-y EBITDA Growth Rate % | -66.20 |
| EV-to-EBIT | 64.47 |
| EV-to-EBITDA | 42.58 |
| PEG | 5.06 |
| Shares Outstanding M | 221.02 |
| Net Margin (%) | 10.89 |
| Operating Margin % | 47.07 |
| Pre-tax Margin (%) | 8.11 |
| Quick Ratio | 3.96 |
| Current Ratio | 4.52 |
| ROA % (ttm) | 3.82 |
| ROE % (ttm) | 5.94 |
| ROIC % (ttm) | 22.11 |
| Dividend Yield % | -- |
| Altman Z-Score | 5.10 |
ALXN Number of Guru Trades
ALXN Volume of Guru Trades
Gurus Latest Trades with NAS:ALXN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ALXN is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Alexion Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:ALXN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers